| Heart disease and stroke statistics—2017 update: a report from the American Heart Association EJ Benjamin, MJ Blaha, SE Chiuve, M Cushman, SR Das, R Deo, ... circulation 135 (10), e146-e603, 2017 | 47435* | 2017 |
| Heart disease and stroke statistics—2016 update: a report from the American Heart Association D Mozaffarian, EJ Benjamin, AS Go, DK Arnett, MJ Blaha, M Cushman, ... circulation 133 (4), e38-e360, 2016 | 28491* | 2016 |
| 2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American … NJ Stone, JG Robinson, AH Lichtenstein, CN Bairey Merz, CB Blum, ... Circulation 129 (25_suppl_2), S1-S45, 2014 | 10481 | 2014 |
| Comprehensive genomic characterization defines human glioblastoma genes and core pathways Cancer Genome Atlas Research Network Tissue source sites: Duke University ... Nature 455 (7216), 1061-1068, 2008 | 7313 | 2008 |
| 2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on … CT January, LS Wann, JS Alpert, H Calkins, JE Cigarroa, JC Cleveland, ... Journal of the American College of Cardiology 64 (21), e1-e76, 2014 | 6988 | 2014 |
| 2013 ACC/AHA guideline on the assessment of cardiovascular risk: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines DC Goff Jr, DM Lloyd-Jones, G Bennett, S Coady, RB D’agostino, ... Circulation 129 (25_suppl_2), S49-S73, 2014 | 6958 | 2014 |
| Efficacy and safety of alirocumab in reducing lipids and cardiovascular events JG Robinson, M Farnier, M Krempf, J Bergeron, G Luc, M Averna, ... New England Journal of Medicine 372 (16), 1489-1499, 2015 | 2397 | 2015 |
| Efficacy and safety of evolocumab in reducing lipids and cardiovascular events MS Sabatine, RP Giugliano, SD Wiviott, FJ Raal, DJ Blom, J Robinson, ... New England Journal of Medicine 372 (16), 1500-1509, 2015 | 1666 | 2015 |
| Dietary fats and cardiovascular disease: a presidential advisory from the American Heart Association FM Sacks, AH Lichtenstein, JHY Wu, LJ Appel, MA Creager, ... Circulation 136 (3), e1-e23, 2017 | 1444 | 2017 |
| Familial hypercholesterolemia: screening, diagnosis and management of pediatric and adult patients: clinical guidance from the National Lipid Association Expert Panel on … AC Goldberg, PN Hopkins, PP Toth, CM Ballantyne, DJ Rader, ... Journal of clinical lipidology 5 (3), 133-140, 2011 | 987 | 2011 |
| Loss-of-Function Mutations in APOC3, Triglycerides, and Coronary Disease TG and HDL Working Group of the Exome Sequencing Project, National Heart ... New England Journal of Medicine 371 (1), 22-31, 2014 | 823 | 2014 |
| HMG-coenzyme A reductase inhibition, type 2 diabetes, and bodyweight: evidence from genetic analysis and randomised trials DI Swerdlow, D Preiss, KB Kuchenbaecker, MV Holmes, JEL Engmann, ... The Lancet 385 (9965), 351-361, 2015 | 731 | 2015 |
| Noninvasive pulse wave analysis for the early detection of vascular disease JN Cohn, S Finkelstein, G McVeigh, D Morgan, L LeMay, J Robinson, ... Hypertension 26 (3), 503-508, 1995 | 718 | 1995 |
| Variation in PCSK9 and HMGCR and Risk of Cardiovascular Disease and Diabetes BA Ference, JG Robinson, RD Brook, AL Catapano, MJ Chapman, ... New England Journal of Medicine 375 (22), 2144-2153, 2016 | 713 | 2016 |
| Meta-analysis of the relationship between non–high-density lipoprotein cholesterol reduction and coronary heart disease risk JG Robinson, S Wang, BJ Smith, TA Jacobson Journal of the American College of Cardiology 53 (4), 316-322, 2009 | 629 | 2009 |
| Effect of evolocumab or ezetimibe added to moderate-or high-intensity statin therapy on LDL-C lowering in patients with hypercholesterolemia: the LAPLACE-2 randomized clinical … JG Robinson, BS Nedergaard, WJ Rogers, J Fialkow, JM Neutel, ... Jama 311 (18), 1870-1883, 2014 | 623 | 2014 |
| Optimism, cynical hostility, and incident coronary heart disease and mortality in the Women’s Health Initiative HA Tindle, YF Chang, LH Kuller, JAE Manson, JG Robinson, MC Rosal, ... Circulation 120 (8), 656-662, 2009 | 601 | 2009 |
| Pleiotropic effects of statins: benefit beyond cholesterol reduction? A meta-regression analysis JG Robinson, B Smith, N Maheshwari, H Schrott Journal of the American college of cardiology 46 (10), 1855-1862, 2005 | 567 | 2005 |
| Cognitive function in a randomized trial of evolocumab RP Giugliano, F Mach, K Zavitz, C Kurtz, K Im, E Kanevsky, J Schneider, ... New England Journal of Medicine 377 (7), 633-643, 2017 | 499 | 2017 |
| Association between baseline LDL-C level and total and cardiovascular mortality after LDL-C lowering: a systematic review and meta-analysis EP Navarese, JG Robinson, M Kowalewski, M Kołodziejczak, F Andreotti, ... Jama 319 (15), 1566-1579, 2018 | 474 | 2018 |
